Predictive analysis of catecholamines and electrolytes for recurrence of orthostatic intolerance in children.
catecholamines
children
electrolytes
orthostatic intolerance
prediction of recurrence
urine test
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2023
2023
Historique:
received:
11
05
2023
accepted:
08
08
2023
medline:
14
9
2023
pubmed:
14
9
2023
entrez:
14
9
2023
Statut:
epublish
Résumé
Orthostatic intolerance (OI) is usually mediated by the autonomic nerve and most often happens in the upright position. However, it can also occur in other positions and can be relieved by lying down while likely to have another attack after relief. In the current study, we aim to evaluate the predictive effect of catecholamines and electrolytes on the recurrence of OI in children. Children who were diagnosed with vasovagal syncope (VVS), postural tachycardia syndrome (POTS), and VVS combined with POTS were enrolled in this retrospective study and were followed up after 1-year physical treatment. Catecholamines in urine collected within 24 h, renin, angiotensin II, aldosterone in plasma, and electrolytes in both blood and urine collected in the morning were tested. A multivariate analysis and a receiver operating characteristic curve were used to validate the prediction effect. In the VVS cohort, the 24 h urine adrenaline (AD) and norepinephrine (NE) levels of the non-recurrence group were lower than the 24 h urine AD and NE levels of the recurrence group, with a significant difference of The study provides further evidence that AD, NE, and electrolytes in urine are promising factors that are closely related to the recurrence of OI in children. The integrated evaluation system merging AD and NE may have better predictive ability.
Sections du résumé
Background
UNASSIGNED
Orthostatic intolerance (OI) is usually mediated by the autonomic nerve and most often happens in the upright position. However, it can also occur in other positions and can be relieved by lying down while likely to have another attack after relief. In the current study, we aim to evaluate the predictive effect of catecholamines and electrolytes on the recurrence of OI in children.
Materials and methods
UNASSIGNED
Children who were diagnosed with vasovagal syncope (VVS), postural tachycardia syndrome (POTS), and VVS combined with POTS were enrolled in this retrospective study and were followed up after 1-year physical treatment. Catecholamines in urine collected within 24 h, renin, angiotensin II, aldosterone in plasma, and electrolytes in both blood and urine collected in the morning were tested. A multivariate analysis and a receiver operating characteristic curve were used to validate the prediction effect.
Results
UNASSIGNED
In the VVS cohort, the 24 h urine adrenaline (AD) and norepinephrine (NE) levels of the non-recurrence group were lower than the 24 h urine AD and NE levels of the recurrence group, with a significant difference of
Conclusion
UNASSIGNED
The study provides further evidence that AD, NE, and electrolytes in urine are promising factors that are closely related to the recurrence of OI in children. The integrated evaluation system merging AD and NE may have better predictive ability.
Identifiants
pubmed: 37705599
doi: 10.3389/fped.2023.1220990
pmc: PMC10495584
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1220990Informations de copyright
© 2023 Chang, Peng, Liu, Wang, Li, Kong, Zhao and Zhao.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Pediatrics. 2014 Jan;133(1):e138-42
pubmed: 24366986
J Am Coll Cardiol. 2021 May 4;77(17):2174-2184
pubmed: 33926653
J Am Heart Assoc. 2019 Jun 18;8(12):e012559
pubmed: 31208249
J Pediatr. 2012 Aug;161(2):281-4
pubmed: 22424949
J Am Coll Cardiol. 2019 Mar 19;73(10):1207-1228
pubmed: 30871704
Sci Bull (Beijing). 2018 Dec 15;63(23):1558-1564
pubmed: 36751076
Eur Heart J. 2018 Jun 1;39(21):1883-1948
pubmed: 29562304
Heart Rhythm. 2017 Aug;14(8):e155-e217
pubmed: 28286247
Drugs. 2018 Jul;78(10):983-994
pubmed: 29943373
Med Sci Monit. 2011 Jun;17(6):PH49-53
pubmed: 21629199
Neurosci Bull. 2020 Jun;36(6):667-681
pubmed: 32367250
QJM. 2016 Dec;109(12):767-773
pubmed: 27340222
Hypertension. 2004 Apr;43(4):809-13
pubmed: 14981050
World J Pediatr. 2021 Feb;17(1):58-62
pubmed: 32405708
Europace. 2003 Jan;5(1):65-70
pubmed: 12504643
J Am Heart Assoc. 2019 Jun 18;8(12):e013129
pubmed: 31208247
Zentralbl Bakteriol Orig. 1968 May;206(4):462-73
pubmed: 5744271
Circulation. 2005 Feb 22;111(7):839-45
pubmed: 15699262
Heart Rhythm. 2015 Jun;12(6):e41-63
pubmed: 25980576
Clin Auton Res. 2021 Jun;31(3):369-384
pubmed: 33740206
Hypertension. 2011 Aug;58(2):167-75
pubmed: 21690484
Front Cardiovasc Med. 2021 Jun 29;8:667171
pubmed: 34268342
Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Oct 18;54(5):954-960
pubmed: 36241239
Am J Med. 2020 Dec;133(12):1471-1478.e4
pubmed: 32603788
Front Pediatr. 2022 Apr 08;10:870939
pubmed: 35463909
Front Cardiovasc Med. 2020 May 06;7:76
pubmed: 32478097
Rev Esp Cardiol (Engl Ed). 2018 Oct;71(10):837
pubmed: 30266166
Am J Cardiol. 1997 May 1;79(9):1302-6
pubmed: 9164914
J Am Coll Cardiol. 1999 Jun;33(7):2059-66
pubmed: 10362214
Cardiol J. 2011;18(5):527-31
pubmed: 21947988
Front Pediatr. 2021 May 13;9:663016
pubmed: 34055695